Filing search / Olema Pharmaceuticals, Inc. / "Long-term"

Search information

Olema Pharmaceuticals, Inc.

Companies

"Long-term"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

28 results

Newest first Best match first

10-Q

2024 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

securities Prepaid expenses and other current assets Total current assets Operating lease right-of-use assets Other assets and long-term deposits Total … expense Changes in operating assets and liabilities: Prepaid expenses and other current assets Other assets and long-term deposits Accounts payable

6 Aug 24

4:15pm

10-Q

2024 Q1

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

securities Prepaid expenses and other current assets Total current assets Operating lease right-of-use assets Other assets and long-term deposits Total … Changes in operating assets and liabilities: Prepaid expenses and other current assets Other assets and long-term deposits Accounts payable Other current

8 May 24

4:15pm

DEF 14A

OLMA Olema Pharmaceuticals, Inc.

Definitive proxy

background, perspective and experience; requirements of applicable law; and having the commitment to rigorously represent the long-term interests … and the long-term interests of stockholders. In conducting this assessment, the Nominating and Corporate Governance Committee typically considers

26 Apr 24

5:07pm

10-K

2023 FY

OLMA Olema Pharmaceuticals, Inc.

Annual report

to continue as a going concern over the long term. We are substantially dependent on the success of our lead product candidate, palazestrant, which … of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term

11 Mar 24

4:15pm

10-K

2023 FY

EX-1.1

OLMA Olema Pharmaceuticals, Inc.

Annual report

), short-term debt or long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside

11 Mar 24

4:15pm

Entry into a Material Definitive Agreement

7 Nov 23

4:12pm

Olema Oncology Announces Combined Financing for Up to $180 Million

Olema Oncology Announces Combined Financing for Up to $180 Million

8 Aug 23

4:12pm

10-Q

x19m00tk3oc5m

Quarterly report

9 May 23

4:08pm

DEF 14A

tciis681

Definitive proxy

28 Apr 23

4:05pm

10-Q

g1d7di

Quarterly report

8 Nov 22

4:45pm

10-Q

cai0fkmz1r icy4

Quarterly report

9 Aug 22

12:00am

10-Q

htwh6dnuxrw jvnlqk

Quarterly report

9 May 22

4:44pm

DEF 14A

u8j3lk mqb02t1

Definitive proxy

28 Apr 22

4:25pm

10-K

qku25ek

Annual report

28 Feb 22

4:56pm

10-Q

wg1j9612fd5d 4qw

Quarterly report

10 Nov 21

4:21pm

10-Q

1ypi70 3qm

Quarterly report

10 Aug 21

4:18pm

Filing search / Olema Pharmaceuticals, Inc. / "Long-term"

28 results

Top filers

Top filing types

Recent filing years